Impact of pretreatment body mass index on the survival of head and neck cancer patients.

Zheng YangJobran MansourPeng SunPeng WeiKristina R DahlstromMark ZafereoGuojun Li Neil D Gross

Published in: Head & neck (2024)

This exploratory analysis suggests that pretreatment BMI could be an independent prognostic factor of survival outcomes in SCCHN patients, particularly in patients with HPV-positive oropharyngeal cancer tumors. Further prospective investigations are warranted.

Keyphrases

prognostic factors
body mass index
end stage renal disease
ejection fraction
newly diagnosed
physical activity
weight gain
high grade
papillary thyroid
weight loss